Summary
Context and ObjectivesRegulatory and ethics bodies in Low- and Middle-Income Countries (LMICs) require well-trained experts to rapidly assess therapeutic and vaccine clinical trials, especially during infectious disease outbreaks. The COVID-19 pandemic exposed significant gaps...